Eupraxia Pharmaceuticals Inc (EPRX)

05:58 AM

Quantitative breakdown of Eupraxia Pharmaceuticals Inc. recent movePortfolio Risk Summary & Weekly Breakout Watchlists - newser.com

05:58 AM

03:19 AM

Will Eupraxia Pharmaceuticals Inc. stock outperform Nasdaq indexEarnings Beat & High Accuracy Swing Trade Signals - newser.com

03:19 AM

01:57 AM

Is Eupraxia Pharmaceuticals Inc. (X43) stock considered safe havenShare Buyback & Verified Momentum Stock Watchlist - newser.com

01:57 AM

Oct 05, 2025

(EPRX.WT.A) Trading Report (EPRX.WT.A:CA) - news.stocktradersdaily.com

Oct 05, 2025

Oct 05, 2025

Why Eupraxia Pharmaceuticals Inc. is moving today2025 Bull vs Bear & Verified Entry Point Detection - newser.com

Oct 05, 2025

Oct 05, 2025

Historical volatility pattern of Eupraxia Pharmaceuticals Inc. visualizedJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com

Oct 05, 2025

Oct 05, 2025

Measuring Eupraxia Pharmaceuticals Inc.’s beta against major indices2025 Trading Recap & Daily Growth Stock Investment Tips - newser.com

Oct 05, 2025

Oct 05, 2025

Technical analysis overview for Eupraxia Pharmaceuticals Inc. stock2025 Analyst Calls & Safe Entry Point Identification - newser.com

Oct 05, 2025

Oct 04, 2025

(EPRX) Technical Pivots with Risk Controls (EPRX:CA) - news.stocktradersdaily.com

Oct 04, 2025

Oct 04, 2025

This small Canadian pharma stock is undervalued, analyst says - Cantech Letter

Oct 04, 2025

Oct 03, 2025

Eupraxia Pharmaceuticals Reports Positive Results in EoE Trial and Plans Expansion - MSN

Oct 03, 2025

Oct 03, 2025

Can Eupraxia Pharmaceuticals Inc. stock double in next 5 yearsJuly 2025 Institutional & Safe Capital Investment Plans - newser.com

Oct 03, 2025

Oct 03, 2025

Why Eupraxia Pharmaceuticals Inc. (X43) stock could outperform next year2025 Price Targets & Entry Point Confirmation Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Will Eupraxia Pharmaceuticals Inc. (X43) stock beat Nasdaq index returnsLayoff News & Real-Time Volume Surge Alerts - newser.com

Oct 03, 2025

Oct 02, 2025

What’s next for Eupraxia Pharmaceuticals Inc. stock price2025 Fundamental Recap & Weekly High Momentum Picks - newser.com

Oct 02, 2025

Oct 01, 2025

Trend Tracker for (EPRX) (EPRX:CA) - news.stocktradersdaily.com

Oct 01, 2025

Oct 01, 2025

Eupraxia Pharmaceuticals Closes $80.5 Million Public Offering - MSN

Oct 01, 2025

Oct 01, 2025

Can Eupraxia Pharmaceuticals Inc. (X43) stock attract analyst upgradesQuarterly Profit Review & Community Verified Watchlist Alerts - newser.com

Oct 01, 2025

Sep 30, 2025

Eupraxia Reports Encouraging Safety And Efficacy Data From Eosinophilic Esophagitis Study - Benzinga

Sep 30, 2025

Sep 30, 2025

Eupraxia Pharmaceuticals stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Nigeria

Sep 30, 2025

Sep 30, 2025

Eupraxia Pharmaceuticals stock maintains Overweight rating at Cantor Fitzgerald - Investing.com India

Sep 30, 2025

Sep 30, 2025

Eupraxia Pharmaceuticals Inc X43 Stock Analysis and ForecastStock Market Trends & Start Small. End Wealthy. - earlytimes.in

Sep 30, 2025

Sep 30, 2025

Eupraxia Pharmaceuticals Announces Positive Data from - GlobeNewswire

Sep 30, 2025

Sep 29, 2025

Will Supply Chain Issues Impact Ethos Limiteds PerformanceCash Flow Trends & Big Data Market Reports - earlytimes.in

Sep 29, 2025

Sep 29, 2025

Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs - GlobeNewswire

Sep 29, 2025

Sep 29, 2025

Eupraxia Pharmaceuticals announces positive data from highest-dose cohort in the ongoing resolve trial in Eosinophilic Esophagitis - TradingView

Sep 29, 2025

Sep 29, 2025

Breakthrough EoE Treatment Success: Eupraxia's EP-104GI Shows Best-in-Class Results at 8mg Dose Level - Stock Titan

Sep 29, 2025